Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 34.46 is 69% above its 4-year average of 20.39, near the high end of its 4-year range (0.00–44.33).
As of the fiscal period ended Tuesday, June 30, 2026. 5.60% above its 12-month average of 32.64.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 34.46.
CURRENT RATIO
34.46
CURRENT RATIO AVG TTM
32.64
CURRENT RATIO AVG 3Y
25.25
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+5.60%
CURRENT VS 3Y AVG
+36.48%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 687 covered companies
CURRENT VS SECTOR MEDIAN
+890.33%
vs the sector median at left
Mineralys Therapeutics, Inc.
Market Cap
$2.03B
Current Ratio
34.46
TTM Avg
32.64
3Y Avg
25.25
5Y Avg
N/A
Market Cap
$2.03B
Current Ratio
5.42
TTM Avg
4.91
3Y Avg
6.23
5Y Avg
8.44
Market Cap
$2.00B
Current Ratio
8.55
TTM Avg
6.61
3Y Avg
7.37
5Y Avg
8.17
Market Cap
$2.06B
Current Ratio
2.32
TTM Avg
2.34
3Y Avg
3.23
5Y Avg
3.57
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | $2.03B | 34.46 | 32.64 | 25.25 | N/A |
| Progyny, Inc. (PGNY)vs › | $2.03B | 2.14 | 2.76 | 2.92 | 2.79 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 5.42 | 4.91 | 6.23 | 8.44 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.00B | 8.55 | 6.61 | 7.37 | 8.17 |
| Alvotech (ALVO)vs › | $2.06B | 1.65 | 2.12 | 1.59 | 1.52 |
| Fortrea Holdings Inc. (FTRE)vs › | $2.07B | 0.96 | 0.99 | 1.34 | 1.34 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | 2.32 | 2.34 | 3.23 | 3.57 |
| Immunome, Inc. (IMNM)vs › | $1.97B | 15.08 | 9.38 | 7.12 | 8.07 |
| AxoGen, Inc. (AXGN)vs › | $1.96B | 6.60 | 4.18 | 3.84 | 4.49 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | 3.84 | 3.30 | 3.38 | 3.69 |
Current Ratio
34.46
Quick Ratio
34.46
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 34.46 |
| 2026-03-31 | 44.33 |
| 2025-12-31 | 43.76 |
| 2025-09-30 | 25.50 |
| 2025-06-30 | 15.12 |
| 2025-03-31 | 26.48 |
| 2024-12-31 | 14.02 |
| 2024-09-30 | 8.55 |
| 2024-06-30 | 11.20 |
| 2024-03-31 | 18.06 |
| 2023-12-31 | 23.76 |
| 2023-09-30 | 19.59 |
| 2023-06-30 | 43.42 |
| 2023-03-31 | 26.07 |
| 2022-12-31 | 13.98 |
| 2022-09-30 | 16.88 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 2.20 |
